Skip to Main Content

Paper Details

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617.
bioRxiv
23
2021
B cells, B.1.617, COVID-19, SARS, SARS-CoV, SARS-CoV-2, epitopes, humanized, humanized clone, neutralizing mAb clones, spike receptor binding domain
Author NameAffiliation
Rita E ChenWashington University School of Medicine in St. Louis
Michael S DiamondWashington University School of Medicine in St. Louis
Michael S DiamondWashington University School of Medicine in St. Louis
Craig B WilenYale University
Craig B WilenYale University
  • 1 - 5

Datasets

Release 1.2